Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20221001008Phase 2Not yet recruiting
Phase 2, single-arm trial of cannabis in sleep disorder, sponsored by Khaosuankwang Hospital. Primary endpoint: Sleep quality. Planned start Oct 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20221001008.